Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
JTO Clinical and Research Reports|August 21, 2023
Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer SurgeryHidefumi Takei, Hideo Kunitoh, Masashi Wakabayashi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2015
A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911Kazuhiko Yamada, Hiromi Aono, Yukio Hosomi, et al.
International Journal of Cancer|December 21, 2004
Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer riskTokuki Sakiyama, Takashi Kohno, Sachiyo Mimaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancerTomoya Fukui, Yuichiro Ohe, Koji Tsuta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2014
A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinomaMotonobu Saito, Kouya Shiraishi, Kenji Matsumoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 5, 2008
Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in JapaneseYoshiro Saito, Kimie Sai, Keiko Maekawa, et al.
Drug Metabolism and Pharmacokinetics|November 19, 2010
Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese populationYoshiro Saito, Noboru Yamamoto, Noriko Katori, et al.
BMC Cancer|October 21, 2015
Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014Yusuke Takagi, Yukio Hosomi, Fumihiro Oshita, et al.
Drug Metabolism and Pharmacokinetics|May 17, 2006
Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese populationKeiko Maekawa, Masaya Itoda, Kimie Sai, et al.
Carcinogenesis|August 7, 2010
Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungsTakashi Kohno, Ryutaro Kakinuma, Motoki Iwasaki, et al.
Pageof 16